FDA Approves Subcutaneous Lecanemab Injection for Maintenance Dosing in Early Alzheimer Disease - Prabadin Corp

https://prabadinews.com/

Email

weborders@prabadincorp.com

Call us

+1 (786)-332-3938

FDA Approves Subcutaneous Lecanemab Injection for Maintenance Dosing in Early Alzheimer Disease

Medical Supplies

September 2, 2025

By AdminPrabadin - 4 days ago

0

The subcutaneous injection for maintenance treatment enhances accessibility and reduces infusion time for patients.

administrator